Celladon Garners $43,000,000 New Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    2223 Avenida de la Playa La Jolla, CA 92037
  • Company Description
    Celladon Corporation is an exciting new biotechnology company focused on developing treatments for cardiovascular diseases through the application of scientific discoveries in molecular cardiology.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    The financing will be used to advance its lead investigational product candidate for the treatment of heart failure.
  • M&A Terms
  • Venture Investor
    Pfizer Venture Investments
  • Venture Investor
    Novartis Venture Fund
  • Venture Investor
    Hambrecht & Quist Capital Management
  • Venture Investor
    GBS Venture Partners
  • Venture Investor
    Enterprise Partners Venture Capital
  • Venture Investor
    Johnson & Johnson Development Corporation
  • Venture Investor

Trending on Xconomy